March 2022
1. RHA MS, Han JW, Koh JY, Lee HS, et al
   Impaired antibacterial response of liver sinusoidal Vgamma9(+)Vdelta2(+) T cells in patients with chronic liver disease.
   Gut. 2022;71:605-615.
   

   >> Share

   
   January 2022
2. MULDER MB, van der Eijk AA, GeurtsvanKessel CH, Erler NS, et al
   High antibody response in relation to immunosuppressive blood levels in liver transplant recipients after SARS-CoV-2 vaccination: an observational, cohort study.
   Gut. 2022 Jan 31. pii: gutjnl-2021-326755. doi: 10.1136/gutjnl-2021-326755.
   

   >> Share

   
   
3. BECCHETTI C, Broekhoven AGC, Dahlqvist G, Fraga M, et al
   Humoral response to SARS-CoV-2 infection among liver transplant recipients.
   Gut. 2022 Jan 5. pii: gutjnl-2021-326609. doi: 10.1136/gutjnl-2021-326609.
   

   >> Share

   
   July 2021
4. BELLI LS, Duvoux C, Cortesi PA, Facchetti R, et al
   COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study.
   Gut. 2021 Jul 19. pii: gutjnl-2021-324879. doi: 10.1136/gutjnl-2021-324879.
   

   >> Share

   
   October 2020
5. ZHANG N, Jiang W, Zhang Y, Song TQ, et al
   Individualised tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria.
   Gut. 2020;69:1893-1895.
   

   >> Share

   
   May 2020
6. YANG H, Sun L, Pang Y, Hu D, et al
   Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure.
   Gut. 2020 May 20. pii: gutjnl-2019-319960. doi: 10.1136/gutjnl-2019-319960.
   

   >> Share

   
   March 2020
7. SCHATTENBERG JM
   Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit.
   Gut. 2020 Mar 23. pii: gutjnl-2019-320355. doi: 10.1136/gutjnl-2019-320355.
   

   >> Share

   
   
8. BOSCH J, Gracia-Sancho J, Abraldes JG
   Cirrhosis as new indication for statins.
   Gut. 2020 Mar 5. pii: gutjnl-2019-318237. doi: 10.1136/gutjnl-2019-318237.
   

   >> Share

   
   October 2019
9. LEE SW, Kwon JH, Lee HL, Yoo SH, et al
   Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naive patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis.
   Gut. 2019 Oct 31. pii: gutjnl-2019-318947. doi: 10.1136/gutjnl-2019-318947.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share